DUBLIN--(BUSINESS WIRE)--The "Digital Diabetes Management Market by Product, Device Type, End User - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The digital diabetes management market is projected to reach USD 19.9 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 23.8%.
Factors such as the rising prevalence of diabetes, growing adoption of cloud-based enterprise solutions for diabetes management, increasing penetration of digital platforms and adoption of mobile apps for diabetes management, and technological advancements are driving the growth of the digital diabetes management market. However, high device costs and lack of reimbursement in developing countries and the higher acceptance of traditional diabetes management devices are expected to restrain market growth to a certain extent during the forecast period.
"Apps segment to witness the highest growth during the forecast period."
On the basis of product & service, the digital diabetes management market is segmented into devices, apps, data management software & platforms, and services. The apps segment is expected to register the highest CAGR during the forecast period. The high acceptance of mobile apps for remote monitoring is the major factor driving the growth of this market segment.
"Self/home healthcare end-user segment to register the highest CAGR during the forecast period."
On the basis of end user, the digital diabetes management market is segmented into self/home healthcare, hospitals & specialty diabetes clinics, and academic & research institutes. The self/home healthcare segment is expected to witness the highest CAGR owing to the launch of advanced diabetes management devices for self/home care and the shift of diabetes management from clinical settings to home care, self-administration, and remote monitoring.
Market Dynamics
Drivers
- Increasing Prevalence of Diabetes
- Technological Advancements
- Growing Adoption of Cloud-Based Enterprise Solutions for Diabetes Management
- Increasing Penetration of Digital Platforms and Adoption of Mobile Apps for Diabetes Management
Restraints
- High Cost of Devices and Lack of Reimbursement in Developing Countries
- Higher Acceptance of Traditional Diabetes Management Devices
Opportunities
- Increasing Diabetes-Related Health Expenditure in Emerging Economies
Challenges
- Low Penetration in Developing Economies
- Lack of Data Security
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Digital Diabetes Management Market, By Product & Service
8 Digital Diabetes Management Devices Market, By Type
9 Digital Diabetes Management Market, By End User
10 Digital Diabetes Management Market, By Region
11 Competitive Landscape
12 Company Profiles
- Abbott Laboratories
- Agamatrix, Inc.
- Ascensia Diabetes Care Holdings Ag.
- B. Braun Melsungen AG
- Dariohealth Corporation
- Dexcom, Inc.
- F. Hoffmann-La Roche
- Glooko, Inc.
- Insulet Corporation
- Lifescan, Inc. (A Subsidiary of Johnson & Johnson)
- Medtronic PLC
- Tandem Diabetes Care, Inc.
- Tidepool
For more information about this report visit https://www.researchandmarkets.com/research/h625rx/digital_diabetes?w=4